LT3214083T - Kvinolono junginių gamybos būdas - Google Patents

Kvinolono junginių gamybos būdas

Info

Publication number
LT3214083T
LT3214083T LTEP17163383.7T LT17163383T LT3214083T LT 3214083 T LT3214083 T LT 3214083T LT 17163383 T LT17163383 T LT 17163383T LT 3214083 T LT3214083 T LT 3214083T
Authority
LT
Lithuania
Prior art keywords
manufacture
quinolone compounds
quinolone
compounds
Prior art date
Application number
LTEP17163383.7T
Other languages
English (en)
Inventor
Roger Hanselmann
Maxwell Reeve
Graham Johnson
Original Assignee
Melinta Subsidiary Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Melinta Subsidiary Corp. filed Critical Melinta Subsidiary Corp.
Publication of LT3214083T publication Critical patent/LT3214083T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/02—Gearboxes; Mounting gearing therein
    • F16H57/027—Gearboxes; Mounting gearing therein characterised by means for venting gearboxes, e.g. air breathers
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/02—Gearboxes; Mounting gearing therein
    • F16H57/037—Gearboxes for accommodating differential gearings
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H48/00—Differential gearings
    • F16H48/06—Differential gearings with gears having orbital motion
    • F16H48/08—Differential gearings with gears having orbital motion comprising bevel gears
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/04—Features relating to lubrication or cooling or heating
    • F16H57/0457—Splash lubrication
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16H—GEARING
    • F16H57/00—General details of gearing
    • F16H57/04—Features relating to lubrication or cooling or heating
    • F16H57/048—Type of gearings to be lubricated, cooled or heated
    • F16H57/0482—Gearings with gears having orbital motion
    • F16H57/0483—Axle or inter-axle differentials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00—Machine element or mechanism
    • Y10T74/19—Gearing
    • Y10T74/19642—Directly cooperating gears
    • Y10T74/19688—Bevel
    • Y10T74/19693—Motor vehicle drive
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T74/00—Machine element or mechanism
    • Y10T74/21—Elements
    • Y10T74/2186—Gear casings
    • Y10T74/2188—Axle and torque tubes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
LTEP17163383.7T 2008-09-24 2009-09-23 Kvinolono junginių gamybos būdas LT3214083T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19408308P 2008-09-24 2008-09-24

Publications (1)

Publication Number Publication Date
LT3214083T true LT3214083T (lt) 2021-01-25

Family

ID=42060333

Family Applications (3)

Application Number Title Priority Date Filing Date
LTEP20191961.0T LT3766876T (lt) 2008-09-24 2009-09-23 Farmacinė vaisto forma, turinti chinolono darinį
LTEP17163383.7T LT3214083T (lt) 2008-09-24 2009-09-23 Kvinolono junginių gamybos būdas
LTPA2021002C LTC3214083I2 (lt) 2008-09-24 2021-02-17 Kvinolono junginių gamybos būdas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LTEP20191961.0T LT3766876T (lt) 2008-09-24 2009-09-23 Farmacinė vaisto forma, turinti chinolono darinį

Family Applications After (1)

Application Number Title Priority Date Filing Date
LTPA2021002C LTC3214083I2 (lt) 2008-09-24 2021-02-17 Kvinolono junginių gamybos būdas

Country Status (28)

Country Link
US (3) USRE46617E1 (lt)
EP (3) EP2346855B1 (lt)
JP (2) JP6013734B2 (lt)
KR (3) KR20170039758A (lt)
CN (2) CN102164912B (lt)
AU (1) AU2009297085B2 (lt)
BR (1) BRPI0919241B8 (lt)
CA (1) CA2738236C (lt)
CY (2) CY1123658T1 (lt)
DK (2) DK2346855T3 (lt)
ES (3) ES2629466T3 (lt)
FI (2) FI3766876T3 (lt)
HK (1) HK1214243A1 (lt)
HR (1) HRP20201879T1 (lt)
HU (2) HUE052219T2 (lt)
IL (1) IL211845A (lt)
LT (3) LT3766876T (lt)
MX (3) MX2011003122A (lt)
NL (1) NL301091I2 (lt)
NO (1) NO2021006I1 (lt)
PL (2) PL3214083T3 (lt)
PT (1) PT3214083T (lt)
RS (1) RS61194B1 (lt)
RU (1) RU2546667C2 (lt)
SG (1) SG10201605492YA (lt)
SI (1) SI3214083T1 (lt)
SM (1) SMT202000690T1 (lt)
WO (1) WO2010036329A2 (lt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7576216B2 (en) * 2004-07-30 2009-08-18 Abbott Laboratories Preparation of pyridonecarboxylic acid antibacterials
SMT202000690T1 (it) * 2008-09-24 2021-01-05 Melinta Subsidiary Corp Processo per la realizzazione di composti di chinolone
TW201444558A (zh) * 2013-03-15 2014-12-01 Melinta Therapeutics Inc 使用喹諾酮類抗生素治療淋病感染的方法
CN104098548B (zh) * 2013-04-11 2017-07-18 上海医药工业研究院 一种Delafloxacin的精制方法
CN103709100A (zh) * 2013-12-31 2014-04-09 南京工业大学 一种8-氯代喹诺酮衍生物的制备方法
TW201605447A (zh) * 2014-06-20 2016-02-16 美林塔治療學有限公司 處理感染的方法
CN106256824B (zh) * 2015-06-18 2020-10-27 重庆医药工业研究院有限责任公司 一种高纯度德拉沙星葡甲胺盐的制备方法
CN105017224A (zh) * 2015-07-10 2015-11-04 扬子江药业集团有限公司 一种德拉沙星葡甲胺晶型的制备方法
CN107778293B (zh) * 2016-08-29 2023-06-16 鲁南制药集团股份有限公司 一种改进的德拉沙星的制备方法
KR20190122762A (ko) 2017-03-31 2019-10-30 후지필름 가부시키가이샤 4-피리돈 화합물 또는 그 염, 그것을 포함하는 의약 조성물 및 제
WO2022240897A1 (en) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Pharmaceutical composition comprising delafloxacin for administration into the lung
CN113527262B (zh) * 2021-06-22 2022-07-15 安徽普利药业有限公司 一种德拉沙星及其葡甲胺盐的精制方法
CN114031607B (zh) * 2021-11-16 2023-01-10 海南普利制药股份有限公司 一种德拉沙星及其中间体的精制方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
RU2171252C2 (ru) * 1995-09-22 2001-07-27 Вакунага Фармасьютикал КО., Лтд. Аминосоединение для получения новых производных пиридонкарбоновой кислоты или их солей
CA2376760C (en) * 1999-07-01 2008-11-25 Wakunaga Pharmaceutical Co., Ltd. Quinolinecarboxylic acid derivative or salts thereof
JP2005097116A (ja) 1999-11-11 2005-04-14 Wakunaga Pharmaceut Co Ltd キノリンカルボン酸誘導体アルカリ金属塩及びこれを用いたキノリンカルボン酸誘導体の精製法
EP2816033A1 (en) 2004-07-30 2014-12-24 Abbvie Inc. Preparation of pyridonecarboxylic acid antibacterials
ES2901955T3 (es) 2004-10-08 2022-03-24 Abbvie Inc Sal meglumínica y formas cristalinas de la misma de un farmaco (delafloxacina)
ATE549016T1 (de) * 2005-04-11 2012-03-15 Abbott Lab Pharmazeutische zusammensetzungen mit verbesserten auflöseprofilen für schwerlösliche wirkstoffe
SMT202000690T1 (it) 2008-09-24 2021-01-05 Melinta Subsidiary Corp Processo per la realizzazione di composti di chinolone

Also Published As

Publication number Publication date
US8497378B2 (en) 2013-07-30
CA2738236A1 (en) 2010-04-01
BRPI0919241A2 (pt) 2016-06-21
HK1214243A1 (zh) 2016-07-22
EP3766876B8 (en) 2023-10-18
JP2015178515A (ja) 2015-10-08
US20140171648A1 (en) 2014-06-19
IL211845A (en) 2017-03-30
BRPI0919241B1 (pt) 2020-05-12
SG10201605492YA (en) 2016-09-29
WO2010036329A3 (en) 2010-07-01
KR20160116020A (ko) 2016-10-06
JP2012508161A (ja) 2012-04-05
EP3766876B1 (en) 2023-09-13
NL301091I2 (nl) 2021-08-03
LT3766876T (lt) 2023-12-11
CN102164912B (zh) 2015-08-19
EP3214083A1 (en) 2017-09-06
CY1123658T1 (el) 2021-05-05
HUS2100004I1 (hu) 2021-03-01
HK1244481A1 (en) 2018-08-10
HRP20201879T1 (hr) 2021-01-22
CN105001207A (zh) 2015-10-28
MX2011003122A (es) 2011-07-20
RU2011116052A (ru) 2012-10-27
PT3214083T (pt) 2020-12-04
FIC20210002I1 (fi) 2021-02-16
HUE052219T2 (hu) 2021-04-28
BRPI0919241A8 (pt) 2017-10-17
PL3766876T3 (pl) 2024-04-02
US20120041208A1 (en) 2012-02-16
ES2629466T3 (es) 2017-08-09
US8871938B2 (en) 2014-10-28
ES2826273T3 (es) 2021-05-17
IL211845A0 (en) 2011-06-30
CY2021004I2 (el) 2021-05-05
AU2009297085B2 (en) 2015-07-09
MX377930B (es) 2025-03-10
SMT202000690T1 (it) 2021-01-05
USRE46617E1 (en) 2017-11-28
DK2346855T3 (en) 2017-07-24
EP2346855B1 (en) 2017-04-05
LTC3214083I2 (lt) 2022-06-27
EP3214083B1 (en) 2020-09-16
NO2021006I1 (no) 2021-02-15
PL3214083T3 (pl) 2021-04-06
CY2021004I1 (el) 2021-05-05
JP6013734B2 (ja) 2016-10-25
SI3214083T1 (sl) 2021-02-26
RS61194B1 (sr) 2021-01-29
AU2009297085A1 (en) 2010-04-01
EP3766876A1 (en) 2021-01-20
WO2010036329A2 (en) 2010-04-01
KR101775304B1 (ko) 2017-09-05
EP2346855A4 (en) 2012-07-04
ES2966093T3 (es) 2024-04-18
CA2738236C (en) 2016-11-15
BRPI0919241B8 (pt) 2021-05-25
KR20170039758A (ko) 2017-04-11
FI3766876T3 (fi) 2023-12-05
CN102164912A (zh) 2011-08-24
DK3214083T3 (da) 2020-12-07
KR20110091504A (ko) 2011-08-11
RU2546667C2 (ru) 2015-04-10
LTPA2021002I1 (lt) 2021-03-10
NL301091I1 (nl) 2021-02-10
MX2020009790A (es) 2020-10-12
EP2346855A2 (en) 2011-07-27

Similar Documents

Publication Publication Date Title
LTPA2021002I1 (lt) Kvinolono junginių gamybos būdas
FI20090389L (fi) Menetelmä hissin valmistamisessa
EP2262922A4 (en) PREPARATION OF TUBES
BRPI0919116A2 (pt) método
BR112012004707A2 (pt) método
BR112012000624A2 (pt) método
PL2601979T3 (pl) Sposób sterylizacji
PL2733492T3 (pl) Sposób wykrywania nowotworów
SMT201400023B (it) Analoghi di buprenorfina
EP2456440A4 (en) Quinolinone PDE2 INHIBITORS
PL3299356T3 (pl) Sposób wytwarzania pleuromutylin
DK2313489T3 (da) Fremstillingsmetode
BRPI1012526A2 (pt) método
EP2349335A4 (en) LEVETIRACETAM IMMUNOASSAYS
PL2493466T3 (pl) Nowe przeciwguzowe zastosowanie kabazytakselu
DK2452189T3 (da) Fremgangsmåde til identifikation af forbindelser til behandling af cancer
BRPI1010705A2 (pt) método
FI20095644A0 (fi) Ulokkeen muodostaminen
DK2346661T3 (da) Dannelsesfremgangsmåder
BRPI1012532A2 (pt) método
PL2358641T3 (pl) Sposób wytwarzania tytanianów
PT2492266E (pt) Derivado de 5-hidroxipirimidino-4-carboxamida
DK2326332T3 (da) Fremgangsmåde til behandling af sygdomme
BRPI0916597A2 (pt) Método
PL2440509T3 (pl) Sposób wytwarzania heksafluoropropanu